Papers - KATO, Masashi
-
Actin-binding Protein, Espin: a Novel Metastatic Regulator for Melanoma. Reviewed
Yanagishita T, Yajima I, Kumasaka M, Kawamoto Y, Tsuzuki T, Matsumoto Y, Watanabe D, Kato M.
Mol Cancer Res Vol. 12 ( 3 ) page： 440-6 2014.3
-
GNG2 inhibits invasion of human malignant melanoma cells with decreased FAK activity. Reviewed
Yajima I, Kumasaka MY, Yamanoshita O, Zou C, Li X, Ohgami N, Kato M.
Am J Cancer Res Vol. 4 ( 2 ) page： 182-8 2014.3
-
Expression of proteins associated with adipocyte lipolysis was significantly changed in the adipose tissues of the obese spontaneously hypertensive/NDmcr-cp rat. Reviewed
Chang J, Oikawa S, Iwahashi H, Kitagawa E, Takeuchi I, Yuda M, Kato C, Yamada Y, Ichihara G, Kato M, Ichihara S.
Diabetol Metab Syndr Vol. 6 ( 1 ) page： 8 2014.1
-
Inflammatory monocytes are potent anti-tumor effectors controlled by regulatory CD4+ T cells. Reviewed
Pommier A, Delpoux A, Audemard A, Martin B, Douguet L, Lengagne R, Campion AL, Kato M, Avril MF, Auffray C, Lucas B, Prévost-Blondel A.
Proc Natl Acad Sci USA Vol. 110 ( 32 ) page： 13085-90 2013.8
-
Enhanced constitutive invasion activity in human nontumorigenic keratinocytes exposed to a low level of barium for a long time.
Thang ND, Yajima I, Ohnuma S, Ohgami N, Kumasaka MY, Ichihara G, Kato M.
Envion Toxicol 2013.6
-
Comparison of barium and arsenic concentrations in well drinking water and in human body samples and a novel remediation system for these elements in well drinking water
Kato M, Kumasaka YM, Ohnuma S, Furuta A, Kato Y, Shekhar HU, Kojima M, Koike Y, Thang ND, Ohgami N, Ly TB, Jia X, Yetti H, Naito H, Ichihara G, Yajima I
PLoS ONE Vol. 8 ( 6 ) 2013.6
-
Cyclophosphamide promotes chronic inflammation-dependent immunosuppression and prevents anti-tumor response in melanoma
Sevko A, Sade-Feldman M, Kanterman J, Michels T, Falk C, Ramacher M, Kato M,
J Invest Dermatol Vol. 133 ( 6 ) page： 1610-1619 2013.6
-
Difference in urinary arsenic metabolites of diabetic and non-diabetic subjects in Bangladesh
Nizam S, Kato M, Yatsuya H Khalequzzaman Md, Ohnuma S, Naito H, Nakajima T
Int J Environ Res Public Health Vol. 10 ( 3 ) page： 1006-19 2013.3
-
Anti-tumor Effect of Paclitaxel is Mediated by Inhibition of MDSCs and Chronic Inflammation in the Spontaneous Melanoma Model
Sevko A, Michels T, Vrohlings M, Umansky L, Beckhove P, Kato M, Shurin GV, Shurin MR, Umansky V
J Immunol Vol. 190 ( 5 ) page： 2464-71 2013.3
-
Enhanced carcinogenicity by coexposure to arsenic and iron and a novel remediation system for the elements in well drinking water.
Kumasaka YM, Yamanoshita O, Shimizu S, Ohnuma S, Furuta A, Yajima I, Nizam S, Khalequzzaman M, Shekhar UH, Nakajima T, Kato M.
Arch Toxicol Vol. 87 ( 3 ) page： 439-47 2013.3
-
Hearing impairments caused by genetic and environmental factors.
Ohgami N, Iida M, Yajima I, Tamura H, Ohgami K, Kato M.
Environ Health Prev Med Vol. 18 ( 1 ) page： 10-5 2013.1
-
Tumor-Expressed Inducible Nitric Oxide Synthase Controls Induction of Functional Myeloid-Derived Suppressor Cells through Modulation of Vascular Endothelial Growth Factor Release.
Jayaraman P, Parikh F, Lopez-Rivera E, Hailemichael Y, Clark A, Ma G, Cannan D, Ramacher M, Kato M, Overwijk WW, Chen SH, Umansky VY, Sikora AG
J Immunol Vol. 188 ( 11 ) page： 5365-76 2012.6
-
Cancer-Induced Immunosuppression: IL-18-Elicited Immunoablative NK Cells.
Terme M, Ullrich E, Aymeric L, Meinhardt K, Coudert JD, Desbois M, Ghiringhelli F, Viaud S, Ryffel B, Yagita H, Chen L, Mécheri S, Kaplanski G, Prévost-Blondel A, Kato M, Schultze JL, Tartour E, Kroemer G, Degli-Esposti M, Chaput N, Zitvogel L
Cancer Res Vol. 72 ( 1 ) page： 2757-67 2012.6
-
Barium inhibits arsenic-mediated apoptotic cell death in human squamous cell carcinoma cells.
Yajima I, Uemura N, Nizam S, Khalequzzaman M, Thnag ND, Kumasaka YM, Akhand AA, Shekhar HU, Nakajima T, Kato M
Arch Toxicol Vol. 86 ( 6 ) page： 961-73 2012.6
-
A novel hairless mouse model for malignant melanoma.
Thang ND, Yajima I, Nakagawa K, Tsuzuki T, Kumasaka YM, Ohgami N, Thuy LB, Iwamoto T, Watanabe D, Kato M
J Dermatol Sci Vol. 65 ( 3 ) page： 207-12 2012.3
-
Partial impairment of c-Ret at tyrosine 1062 accelerates age-related hearing loss in mice.
Ohgami N, Ida-Etoh M, Sakashita N, Sone M, Nakashima N, Tabuchi K, Hoshino T, Shimada A, Tsuzuki T, Yamamoto M, Sobue G, Jijiwa M, Asai N, Hara A, Takahashi M, Kato M
Neurobiol Aging Vol. 33 ( 3 ) page： 626.e25-34 2012.3
-
Functional analysis of GNG2 in human malignant melanoma cells.
Yajima I, Kumasaka YM, Tamura H, Ohgami N, Kato M
J Dermatol Sci Vol. 68 ( 3 ) page： 172-8 2012.1
-
c-Ret-mediated hearing losses
Ohgami N, Ida M, Shimotake T, Sakashita N, Sone M, Nakashima T, Tabuchi K, Hoshino T, Shimada A, Tsuzuki T, Yamamoto M, Sobue G, Jijiwa M, Asai N, Hara A, Takahashi M, Kato M
Proc Natl Acad Sci USA Vol. 107 ( 29 ) page： 13051-6 2012
-
RAS/RAF/MEK/ERK and PI3K/PTEN/AKT signaling in malignant melanoma progression and therapy
Yajima I, Kumasaka YM, Thang ND, Goto Y, Takeda K, Yamanoshita O, Iida M, Ohgami N, Tamura H, Kawamoto Y, Kato M
Dermatol Res Prac Vol. 2012 page： 354191 2012
-
c-Ret-mediated hearing losses
Ohgami N, Tamura H, Ohgami K, Iida M, Yajima I, Kumasaka YM, Goto Y, Sone M, Nakashima T, Kato M
Int J Clin Exp Pathol Vol. 5 ( 1 ) page： 23-8 2012